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To clarify surgical outcomes for 5 ophthalmic diseases in terms of vision-related quality of life (QOL),  
we sent a self-administered Visual Function Questionnaire-14 (VF-14) to patients 3 months postopera-
tively,  and the VF-14 scores for the surgical outcome of strabismus were compared with those of 
patients with diabetic macular edema (DME),  cataract,  glaucoma,  and epiretinal membrane (ERM).  
Test-retest repeatability of VF-14 was evaluated with Bland-Altman analysis.  Of the 625 eligible 
patients who were referred for enrollment,  48 with comitant strabismus,  50 with incomitant strabis-
mus,  45 with DME,  38 with cataract,  129 with glaucoma,  and 73 with ERM agreed to answer.  Eighty 
percent of subjects showed 95ｵ limits of agreement with the VF-14 evaluated by repeated measure-
ments.  The gain by surgery for incomitant strabismus was not diﬀerent from that of cataract (p＝
0.5551),  but it was signiﬁcantly better than those of DME (p＝0.0266),  comitant strabismus (p＝0.0128),  
ERM (p＝0.0021),  glaucoma with cataract (p＜0.0001),  and glaucoma alone (p＜0.0001).  The surgical 
outcome in terms of QOL for patients with incomitant strabismus was good and comparable to that of 
patients with cataract surgery.
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he importance of evaluating the outcome of 
medical care from the patientsʼ viewpoint has 
been increasingly recognized.  This patient-oriented 
outcome is characterized by the quantiﬁcation of 
changes in the health-related quality of life (QOL) 
following treatment [1].  Examples are the Medical 
Outcomes Study 36-item Short Form (SF-36),  the 
Sickness Impact Score (SIP),  and utility analysis with 
typical comprehensive scales for QOL assessment 
without restricting the subjects to patients with a 
particular disease.  In the ﬁeld of ophthalmology,  
various vision-related disease-speciﬁc scales have been 
developed to evaluate impairment of visual function and 
therapeutic eﬀects from the patientsʼ viewpoint.  Repre-
sentative examples are the Visual Function Ques-
tionnaire (VF)-14 and the National Institute Visual 
Function Questionnaire (NEI VFQ)-25,  which are 
widely used [2].
　 In recent years,  strabismus,  an impairment in 
visual function,  and the sociopsychological problems 
characteristic of this disease have become recognized,  
and tools including the Amblyopia & Strabismus 
Questionnaire (A&SQ) [3] and the 20-item Adult 
Strabismus Quality of Life Questionnaire (AS-20) 
[4,  5] have been developed to analyze them from the 
viewpoint of QOL.  Furthermore,  methods to evaluate 
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treatments for strabismus by QOL measurement 
according to their economic eﬃciency using cost-eﬀect 
analysis are attracting attention [6,  7].  In particular,  
the socioeconomic disadvantages and psychological 
eﬀects of adult strabismus have come to be perceived 
as problems [8,  9],  and there have been reports on 
various QOL assessments,  typically using NEI VFQ-
25 [3,  4].  In Japan,  there has also been multi-center 
joint research analyzing the eﬀect of strabismus sur-
gery on QOL using NEI VFQ-25 [7].
　 VF-14 is a method for assessing the quality of the 
visual function of those with cataracts in daily living 
from the patientsʼ viewpoint,  developed in 1994 by 
Steinberg et al.  [10].  Its advantage is that it consists 
of fewer questions and can be performed in a shorter 
time than NEI VFQ-25.  In addition,  VF-14 shows a 
close correlation with visual acuity [2,  10,  11,  12] 
and has been reported to be correlated with the pres-
ence or absence of other ophthalmic or systemic disor-
ders [10],  depth perception [12],  and contrast sen-
sitivity [12].  Using VF-14,  we compared the eﬀects 
of surgery for comitant and incomitant strabismus on 
vision-related QOL with those of surgical treatments 
for major ophthalmic diseases including diabetic macu-
lar edema (DME),  cataract,  glaucoma,  and epiretinal 
membrane (ERM),  because there were no compara-
tive visual function scores available after these vari-
ous ophthalmic surgical interventions.
Subjects and Methods
　 Participants. A total of 625 patients who 
underwent surgery at Okayama University Hospital 
between 2005 and 2008,  aged 40 to 85 years,  were 
examined with the self-administered VF-14.  Thirty-
seven normal subjects,  aged 40 or older,  were used as 
a control.  Members of the control group showed deci-
mal corrected visual acuity of 1.0 or more in both eyes 
and had never been diagnosed with any ophthalmic 
disease.
　 This study was carried out with the approval of the 
Ethical Review Board of the Okayama University 
Graduate School of Medicine,  Dentistry and Pharma-
ceutical Sciences.
　 Measurements. VF-14 consists of 14 ques-
tions related to behavioral patterns in daily living that 
are likely to be aﬀected by vision (Table 1),  and the 
respondents chose one of 5 capability levels from ʻnot 
capable at allʼ to ʻperfectly capableʼ.  The answers 
were weighted by scoring ʻnot capable at allʼ as 0 and 
ʻperfectly capableʼ as 4,  the total score of the 14 items 
was divided by the number of questions answered,  and 
the quotient was multiplied by 25 to calculate the total 
score.  The total score was 100 if the answers to all 
questions were ʻperfectly capableʼ and 0 if the answers 
to all questions were ʻnot capable at allʼ.  Six items 
related to binocular vision were chosen from 14 items 
of VF-14,  the score calculated employing the same 
methods concerning the 6 items was determined as 
binocular vision score (Table 1).  The diﬀerence in the 
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Table 1　 Visual function questionnaire-14 (VF-14)
1. Do you have any diﬃculty,  even with glasses,  reading small print,  such as labels on medicine bottles,  a telephone book,  or food 
labels?
2. Do you have any diﬃculty,  even with glasses,  reading a newspaper or a book?
3. Do you have any diﬃculty,  even with glasses,  reading a large-print book or large-print newspaper or the number on a telephone?
4. Do you have any diﬃculty,  even with glasses,  recognizing people when they are close to you?
5.＊ Do you have any diﬃculty,  even with glasses,  seeing steps,  stairs,  or curbs?
6. Do you have any diﬃculty,  even with glasses,  reading traﬃc signs,  street signs,  or store signs?
7.＊ Do you have any diﬃculty,  even with glasses,  doing ﬁne handwork like sewing,  knitting,  crocheting,  or carpentry?
8. Do you have any diﬃculty,  even with glasses,  writing checks or ﬁlling out forms?
9. Do you have any diﬃculty,  even with glasses,  playing games such as bingo,  dominos,  card games,  or mahjong?
10.＊ Do you have any diﬃculty,  even with glasses,  taking part in sports like bowling,  handball,  tennis,  or golf?
11.＊ Do you have any diﬃculty,  even with glasses,  cooking?
12.＊ Do you have any diﬃculty,  even with glasses,  watching television?
13.＊ How much diﬃculty do you have driving during the day because of your vision?
14.＊ How much diﬃculty do you have driving at night because of your vision?
＊Item used to calculate the binocular vision score.
Steinberg EP,  et al.  Arch Ophthalmol,  112,  630-638,  1994.
pre- and postoperative scores in patients with each 
disease was regarded as the gain following surgery for 
that disease.
　 For cataracts,  the lens was removed by pha-
coemulsiﬁcation and an intraocular lens was implanted.  
For DME and ERM,  vitrectomy was performed fol-
lowed by 20-gauge three-port pars plana vitrectomy.  
The crystalline lens was removed by phacoemulsiﬁca-
tion,  and an intraocular lens was implanted when 
required.  Glaucoma patients were divided into those 
who underwent glaucoma surgery by trabeculectomy 
with or without cataract surgery,  and the scores were 
compared.
　 For comitant and incomitant strabismus,  ocular 
deviation was measured,  and the Bagolini striated 
glasses (BSG) test and Titmus stereo test were per-
formed before and after surgery.  Patients were 
instructed to gaze at a ﬁxed object at a distance of 
5m,  and ocular deviation in the primary position was 
measured with the prism and alternate cover test.  
Values were converted from prism diopters to degrees 
for statistical processing.
　 Evaluation of repeatability. Test-retest repeat-
ability of VF-14 was analyzed using a Bland-Altman 
plot [13,  14] in 15 patients with comitant or incomi-
tant strabismus,  in whom VF-14 was performed 2 
times at intervals of 1 to 3 months before surgery.
　 Statistical analysis. Using a non-parametric 
test,  pre- and postoperative VF-14 and binocular 
scores were compared,  and these were also compared 
with control subjects.  In the same way,  the gain from 
surgical intervention was compared between patients 
with incomitant strabismus and those with other dis-
eases.  Multiple regression analysis was used to ana-
lyze relationships between the gain in VF-14 scores 
following the strabismus surgery and other variables 
that aﬀect VF-14 scores.  Analyses were carried out 
using the statistical software JMP (ver.  8.0 SAS 
Institute,  Inc.,  NC,  USA).  P＜0.05 was considered 
signiﬁcant.
Results
　 Of the 625 patients,  383 (61.3ｵ),  including 48 
patients with comitant strabismus,  50 with incomitant 
strabismus,  45 with DME,  38 with cataract,  129 
with glaucoma,  and 73 with ERM,  agreed to answer 
VF-14 (Table 2).  The response rates were 67.2ｵ 
with comitant and incomitant strabismus,  52.5ｵ with 
DME,  41ｵ with cataract,  72.8ｵ with glaucoma,  
and 58.7ｵ with ERM.  Eighty percent of subjects 
showed 95ｵ limits of agreement with the VF-14 
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Table 2　 Subject age and gender
Disease Number of patients
Age Gender
Mean±SD
(Median,  Range)
Male Number (%)
Female Number (%)
DME 45 68.0±9.0(69,  42 to 82)
23 (51.1)
22 (48.9)
Cataract 38 72.0±6.8(74,  52 to 84)
16 (42.1)
22 (57.9)
Incomitant strabismus 50 64.5±10.6(66,  40 to 87)
25 (50.0)
25 (50.0)
Glaucoma alone 57 70.1±11.2(72,  47 to 88)
33 (57.9)
24 (42.1)
Glaucoma (with cataract) 72 73.8±6.8(74,  55 to 89)
34 (47.2)
38 (52.8)
ERM 73 70.2±8.4(71,  49 to 86)
36 (49.3)
37 (50.7)
Comitant strabismus 48 56.6±13.1(54,  40 to 84)
20 (41.7)
28 (58.3)
Normal 37 59.2±8.4(60,  40 to 73)
25 (67.6)
12 (32.4)
DME,  Diabetic macular edema; ERM,  Epiretinal membrane.
evaluated by repeated measurements (Table 3,  Fig.  
1).
　 Of 14 questionnaires,  the pre- and postoperative 
mean number (SD) of responses was 12 (2).  Of 6 
questions related to binocular visual function,  the pre 
and postoperative mean numbers (SD) of responses 
were 4 (1) and 4 (2),  respectively.  The preoperative 
VF-14 scores were signiﬁcantly diﬀerent among dis-
eases (p＜0.0001; Kruskal-Wallis test).  Mean preop-
erative VF-14 scores were 57 with DME,  62 with 
cataract,  67 with incomitant strabismus,  73 with 
glaucoma surgery alone,  74 with glaucoma combined 
with cataract surgery,  76 with ERM,  80 with comi-
tant strabismus,  and 90 with normal control.  VF-14 
scores of the ophthalmic diseases were signiﬁcantly 
lower than those of the normal control (p＝0.005 for 
comitant strabismus,  p＜0.0001 for incomitant stra-
bismus,  DME,  cataract,  glaucoma,  and ERM;  
Wilcoxon rank sum test).  The scores of comitant 
strabismus were signiﬁcantly higher than those of 
cataract and DME (p＝0.0002 in cataract,  p＜0.0001 
in DME; Wilcoxon rank sum test).  The scores of 
incomitant strabismus was signiﬁcantly lower than 
those of comitant strabismus,  ERM,  glaucoma sur-
gery alone,  and glaucoma with cataract surgery (p＝
0.0003 in comitant strabismus,  p＝0.0021 in ERM,  p
＝0.0111 in glaucoma with cataract surgery,  p＝
0.0491 in glaucoma surgery alone; Wilcoxon rank sum 
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Table 3　 VF-14 and binocular vision scores before and after surgery
Disease VF-14 score Binocular vision score
Before surgery After surgery Before surgery After surgery
Mean±SD
Median
(Range)
Mean±SD
Median
(Range)
Mean±SD
Median
(Range)
Mean±SD
Median
(Range)
DME 57±27
61
(4 to 94)
66±24
67
(11 to 100)
59±31
63
(0 to 100)
71±27
75
(8 to 100)
Cataract 62±22
63
(10 to 100)
84±16
91
(54 to 100)
64±24
75
(6 to 100)
84±19
90
(33 to 100)
Incomitant strabismus 67±18
65
(29 to 100)
85±14
88
(50 to 100)
64±20
65
(25 to 100)
83±16
85
(25 to 100)
Glaucoma alone 73±22
76
(5 to 100)
69±25
70
(4 to 100)
73±23
75
(8 to 100)
68±26
71
(0 to 100)
Glaucoma (with cataract) 74±20
79
(4 to 100)
77±19
80
(21 to 100)
74±23
80
(4 to 100)
75±21
75
(17 to 100)
ERM 76±17
79
(4 to 100)
82±16
85
(8 to 100)
77±19
79
(5 to 100)
82±17
83
(6 to 100)
Comitant strabismus 80±17
8
4(46 to 100)
88±13
93
(55 to 100)
77±19
82
(35 to 100)
87±14
92
(38 to 100)
Normal 90±10
93
(59 to 100)
92±9
95
(65 to 100)
DME,  Diabetic macular edema; ERM,  Epiretinal membrane.
test) (Table 3,  Fig.  2).
　 The postoperative VF-14 scores were signiﬁcantly 
diﬀerent among diseases (p＜0.0001; Kruskal-Wallis 
test).  The mean postoperative VF-14 scores were 66 
with DME,  69 with glaucoma surgery alone,  77 with 
glaucoma combined with cataract surgery,  82 with 
ERM,  84 with cataract,  85 with incomitant strabis-
mus,  and 88 with comitant strabismus.  Postoperative 
VF-14 scores increased signiﬁcantly compared to 
those of preoperative scores except for glaucoma.  The 
postoperative VF-14 scores of strabismus and cataract 
surgery did not signiﬁcantly diﬀer from normal con-
trols,  but the scores of comitant strabismus were 
signiﬁcantly higher than those of ERM (p＝0.0202),  
glaucoma combined with cataract surgery (p＝0.0008),  
glaucoma surgery alone (p＜0.0001),  and DME (p＜
0.0001; Wilcoxon rank sum test).  The scores of 
incomitant strabismus were signiﬁcantly higher than 
those of glaucoma combined with cataract surgery (p
＝0.0163),  glaucoma surgery alone (p＝0.0002),  and 
DME (p＜0.0001; Wilcoxon rank sum test) (Table 3,  
Fig.  2).
　 The binocular vision scores also increased signiﬁ-
cantly postoperatively,  except in those with glaucoma.  
The preoperative VF-14 and binocular vision scores 
were compared in each disease.  In comitant strabis-
mus,  the binocular vision score was signiﬁcantly lower 
than the VF-14 score (p＝0.0039,  Wilcoxon signed-
rank test).  However,  no signiﬁcant diﬀerence was 
noted between the 2 scores in other diseases,  includ-
ing incomitant strabismus.  Postoperatively,  no sig-
niﬁcant diﬀerence was noted between the 2 scores in 
comitant and incomitant strabismus (p＝0.2909 in 
comitant strabismus,  p＝0.4284 in incomitant strabis-
mus; Wilcoxon signed-rank test) (Table 3).
　 The gain in VF-14 scores was signiﬁcantly diﬀer-
ent among diseases (p＜0.0001; Kruskal-Wallis test).  
The mean gains in VF-14 score were 22 with cataract,  
19 with incomitant strabismus,  9 with DME,  8 with 
comitant strabismus,  6 with ERM,  3 with glaucoma 
combined with cataract surgery,  and -4 with glaucoma 
surgery alone.  The gain following surgery for incomi-
tant strabismus was not diﬀerent from that for cata-
ract surgery (p＝0.5551,  Wilcoxon rank sum test),  
but it was signiﬁcantly larger than those for DME (p
＝0.0266),  comitant strabismus (p＝0.0128),  ERM 
(p＝0.0021),  glaucoma combined with cataract sur-
gery (p＜0.0001),  and glaucoma surgery alone (p＜
0.0001,  Wilcoxon rank sum test).  The gain in the 
score for comitant strabismus was not diﬀerent from 
that for DME (p＝0.7062),  ERM (p＝0.6993),  or 
glaucoma combined with cataract surgery (p＝0.1185),  
but it was signiﬁcantly smaller than that for cataract 
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Fig. 1　 Test-retest repeatability of VF-14.  Bland-Altman plots 
showed that test-retest repeatability in the answers to the VF-14 
was good (p＝0.9225).  Eighty percent of subjects showed 95% 
limits of agreement with the VF-14.  The horizontal line indicates the 
mean,  and the vertical line indicates the diﬀerence between two 
VF-14 scores measured at 2 diﬀerent times,  while the dotted line 
indicates the 95% limits of agreement (＝mean diﬀerence ±1.96
×SD of the diﬀerences).
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Fig. 2　 Preoperative and postoperative VF-14 scores.  DME,  
diabetic macular edema; I-Strabismus,  incomitant strabismus; C-
Glaucoma,  glaucoma (with cataract) ERM,  epiretinal membrane;  
C-Strabismus,  comitant strabismus.  ＊p＜0.0001, †p＜0.001, ‡p
＜0.05,  Wilcoxon signed rank test.
surgery (p＝0.0034) and signiﬁcantly larger than that 
for glaucoma surgery alone (p＜0.0001,  Wilcoxon rank 
sum test) (Fig.  3).
　 In the patients with glaucoma,  a signiﬁcant nega-
tive correlation was observed between the preopera-
tive VF-14 score and age.  However,  no signiﬁcant 
correlation was noted in any other disease or control 
(Table 4).  A signiﬁcant negative correlation was 
observed between the preoperative VF-14 score and 
gain in each disease (Table 5).  Gender did not aﬀect 
preoperative or postoperative VF-14 scores or gain in 
any disease either,  except for preoperative VF-14 
score in comitant strabismus (Tables 4 and 5).
　 The gain following surgery for comitant strabismus 
diﬀered by type of strabismus,  but that for incomitant 
strabismus did not diﬀer (Table 6).  In both comitant 
and incomitant strabismus,  ocular deviation decreased 
and binocular function improved after surgery (Table 
7).  Multiple regression analysis showed that the sig-
niﬁcant independent variables that could aﬀect postop-
erative results were age,  preoperative VF-14 score,  
the type of strabismus,  and postoperative diplopia for 
comitant strabismus,  and preoperative VF-14 score,  
preoperative diplopia,  postoperative diplopia,  type of 
strabismus,  and postoperative ocular deviation for 
incomitant strabismus (Table 8).
Discussion
　 A notable diﬀerence between patients with comitant 
strabismus and those with incomitant strabismus 
clariﬁed by VF-14 was a low preoperative VF-14 
score in only those with incomitant strabismus,  
despite visual acuity impairment not being a chief 
complaint in either comitant or incomitant strabismus 
compared with complaints in other diseases,  while 
visual acuity characteristically shows a positive cor-
relation with VF-14 score [2,  10,  11].  Second,  the 
preoperative binocular vision score was signiﬁcantly 
lower than the VF-14 score in patients with comitant 
strabismus,  but there was no signiﬁcant diﬀerence 
between these 2 postoperative scores.  Third,  the gain 
following surgery for incomitant strabismus was the 
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Fig. 3　 The gains in VF-14 scores.  The gains in VF-14 scores 
signiﬁcantly diﬀered among diseases.  I-Strabismus,  incomitant 
strabismus; DME,  diabetic macular edema; C-Strabismus,  comi-
tant strabismus; ERM,  epiretinal membrane; C-Glaucoma,  glau-
coma (with cataract).  p＜0.0001,  Kruskal-Wallis test.
Table 4　 Relationships between the preoperative VF-14 score and age and gender
Age Gender
Disease r p-value
VF-14 score,
 Mean
(Male,  Female)
p-value
DME －0.1194 0.4347　 (55,  59) 0.4957　
Cataract 0.2365 0.1529　 (61,  63) 0.6047　
Incomitant strabismus －0.1590 0.2701　 (68,  65) 0.5219　
Glaucoma alone －0.4054 0.0018＊ (74,  71) 0.4470　
Glaucoma (with cataract) 0.0663 0.5798　 (76,  73) 0.5959　
ERM －0.0868 0.4655　 (74,  78) 0.3179　
Comitant strabismus －0.2778 0.0559　 (75,  84) 0.0423†
Normal 0.0767 0.6516　 (91,  89) 0.7191　
DME,  Diabetic macular edema; ERM,  Epiretinal membrane.
＊p＜0.05,  Spearmanʼs rank correlation coeﬃcient.  †p＜0.05,  Wilcoxon rank sum test.
largest and was comparable to the gain following cata-
ract surgery.  These ﬁndings indicate that the eﬀect of 
diplopia complicating incomitant strabismus on QOL 
is greater than the eﬀect of the impairment in binocu-
lar vision of comitant strabismus on QOL.  The large 
gain following surgery for incomitant strabismus is 
considered to have been due to the resolution of diplo-
pia,  which negatively aﬀects QOL [16,  17].
　 The mean pre- and postoperative VF-14 scores of 
cataract surgery were 62 and 84,  respectively,  and 
the mean surgical gain was 22.  The preoperative 
VF-14 score in cataract patients has been reported to 
be 75.5 [10] or 64-76 [18].  Other studies reported 
that the score improved from 60.99 to 85.11 [19] and 
69.1 to 79.4 [20] postoperatively.  The results of our 
analysis support these reports.  A strong correlation 
with visual acuity [2,  10] and the involvement of 
contrast sensitivity in the improvement in the score 
have been reported as characteristics of the VF-14 
score in patients following cataract surgery [12].  The 
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Table 5　 Relationships between the gain of VF-14 score and age,  gender,  preoperative VF-14 score
Age Gender Preoperative VF-14 score
Disease r p Gain,  mean (Male,  Female) p r p
DME 　0.0845 0.5809　 (15,  4) 0.1731 －0.5491 ＜0.0001†
Cataract －0.2534 0.1248　 (19,  24) 0.4063 －0.6038 ＜0.0001†
Incomitant strabismus 　0.1058 0.4647　 (18,  19) 0.8234 －0.7324 ＜0.0001†
Glaucoma alone 　0.1233 0.3608　 (－4,  －5) 0.9612 －0.3233 0.0142†
Glaucoma (with cataract) －0.0641 0.5926　 (2,  3) 0.7222 －0.4867 ＜0.0001†
ERM －0.0770 0.5204　 (6,  6) 0.6481 －0.5897 ＜0.0001†
Comitant strabismus 　0.4790 0.0006＊ (9,  7) 0.4013 －0.6969 ＜0.0001†
DME,  diabetic macular edema; ERM,  epiretinal membrane.
＊p＜0.05,  Spearmanʼs rank correlation coeﬃcient.  †p＜0.05, Wilcoxon rank sum test.
Table 6　 Type of strabismus,  VF-14 score,  and the gain of VF-14 score
No. of
patients
Preoperative
VF-14 score
(Mean±SD)
Postoperative
VF-14 score
(Mean±SD)
Gain of
VF-14 score
(Mean±SD)
Comitant strabismus
　Intermittent exotropia 19 81±17 91±10 9±14
　Constant exotropia 11 85±17 88±13 3±10
　Esotropia 8 69±13 90±10 21± 6
　Consecutive exotropia 7 81±18 78±19 －3± 9
　Sensory exotropia 2 96± 3 95± 4 －1±14
　Vertical strabismus 1 57 68 11
p-value 0.1013 0.5414 0.0004＊
Incomitant strabismus
　Decompensated SOP 16 72±17 85±15 13±13
　Thyroid opthalmopathy 9 57±21 87±10 30±17
　Fourth nerve palsy 7 61±15 89± 9 28±20
　Third nerve palsy 6 71±17 78±19  7±27
　Restrictive strabismus 5 57±19 82±17 26±31
　Sixth nerve palsy 3 69±13 95±15 26±31
　Blowout fracture 2 72±16 73±11  1± 5
　Others 2 91± 8 92± 9  1± 1
p-value 0.1942 0.7749  0.1612
SOP,  Superior oblique muscle palsy. ＊p＜0.05,  Kruskal-Wallis test.
marked gain is considered to have been achieved due 
to the eﬀect on visual acuity.  It may also be ascribed 
to the absence of other ophthalmic comorbidities,  
because their presence has been reported to impair 
QOL [10,  21] and reduce the gain [22].
　 In glaucoma patients,  the preoperative mean VF-14 
scores were 73 with glaucoma surgery alone and 74 
with glaucoma combined with cataract surgery,  which 
were the third highest next to those in comitant stra-
bismus and ERM patients.  This score for glaucoma 
patients has been reported not to diﬀer from that of 
healthy individuals [23] and was 79.1 in a previous 
study [24],  which is close to the 74 observed in the 
present study.  The VF-14 score has been reported to 
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Table 7　 Preoperative and postoperative characteristics in strabismus group
Comitant strabismus Incomitant strabismus
Preoperative Postoperative Preoperative Postoperative
Angle of strabismus in the primary position (deg), 
Mean±SD
21±10  3±  4 14±  9  4±  6
Percent decrease in ocular deviation (%), 
Mean±SD
83±24 74±36
BSG test,  n (%)
　BSV  7 (14.6) 33 (68.8)  1 (2.1) 29 (59.2)
　Diplopia  6 (12.5)  7 (14.5) 22 (45.8) 13 (26.5)
　Suppression 35 (72.9)  8 (16.7) 25 (52.1)  7 (14.3)
Stereopsis,  n (%)
　≦100sec of arc 17 (35.4) 24 (65.8) 19 (39.6) 28 (59.6)
　120sec of arc≦  3 (6.3)  6 (14.0)  2 (4.2)  7 (14.9)
　(－) 28 (58.3) 13 (30.2) 27 (56.2) 12 (25.5)
Diplopia,  n (%)
　Never 17 (35.4) 21 (43.8)  5 (10.0) 26 (52.0)
　Sometimes 12 (25.0) 21 (43.8)  5 (10.0) 17 (34.0)
　Always 19 (39.6)  6 (12.4) 40 (80.0)  7 (14.0)
BSG,  Bagolini striated glass; BSV,  Binocular single vision.
Table 8　 Multiple regression analysis with the gain of VF-14 score as dependent variable in strabismus group
Partial correlation coeﬃcient p-value
Comitant strabismus
　Age 0.202 　0.0329
　Preoperative VF-14 score －0.469 ＜0.0001
　Type＊ 3.317 　0.0235
　Postoperative diplopia －5.037 　0.0167
　Coeﬃcient of determination (p-value) 0.679 (＜0.0001)
Incomitant strabismus
　Preoperative VF-14 score －0.687 ＜0.0001
　Preoperative diplopia† 5.432 　0.0290
　Postoperative diplopia† －12.025 ＜0.0001
　Type＊＊ 5.470 　0.0123
　Postoperative ocular deviation －2.13 　0.0385
　Coeﬃcient of determination (p-value) 0.789 (＜0.0001)
＊Type of comitant strabismus: sensory exotropia,  consecutive exotropia,  or others,  1; exotropia,  2; intermittent exotropia,  3; esotropia,  
4.
＊＊Type of incomitant strabismus: Blowout fractures or others,  1; third nerve palsy,  2; decompensated superior oblique muscle palsy,  
3; thyroid opthalmopathy,  fourth nerve palsy,  sixth nerve palsy or restrictive strabismus,  4.
†Diplopia: no,  0; sometimes,  1; always,  2.
be signiﬁcantly correlated with visual ﬁeld loss in 
glaucoma [24-26].  However,  the score has been 
reported to be higher than in age-related macular 
degeneration,  which is associated with central visual 
ﬁeld impairment [27],  because the central visual ﬁeld 
loss has a greater eﬀect on QOL than does peripheral 
vision impairment [26].  The gain was smallest in 
glaucoma among the 6 diseases,  but it was larger in 
glaucoma with cataract surgery than in glaucoma sur-
gery alone.  Cataract surgery is considered to achieve 
improved visual acuity,  leading to an improvement in 
QOL.
　 The gain observed in DME was larger than that 
reported previously [28,  29].  Of the 6 diseases,  the 
lowest preoperative VF-14 score was 57 in DME.  
The gain did not diﬀer signiﬁcantly compared with that 
of comitant strabismus,  but it was signiﬁcantly lower 
than that of incomitant strabismus.  According to 
reports using VFQ-25,  the preoperative score in 
DME was lower than that in glaucoma and cataract,  
and was comparable to that in age-related macular 
degeneration [28,  30],  although the gain was smaller 
[28].
　 No eﬀect of age or gender on the preoperative 
VF-14 score or its postoperative gain was noted,  
except in comitant strabismus and glaucoma.  However,  
the gain increased with age in patients with comitant 
strabismus.  This suggests that surgery is likely to 
improve the QOL even in elderly patients with comi-
tant strabismus.  In addition,  the results of this study 
indicate that the type of strabismus aﬀected the 
improvement in vision-related QOL.
　 This study had 2 limitations.  First,  the character-
istics of the participants may have been biased because 
the study was limited to a single facility.  Indications 
for surgery and the severity of target disorders may 
vary among facilities,  and these factors may have 
aﬀected the scores.  Second,  QOL may be evaluated 
diﬀerently between developing and developed countries 
and between urban and rural areas,  owing to diﬀer-
ences in social and economic circumstances [18].  
With these limitations in mind,  it is diﬃcult to con-
clude deﬁnitively that the results of this study reﬂect 
the state of average patients.
　 Our study demonstrated that the surgical outcome 
for incomitant strabismus was comparable to that for 
cataract surgery,  and was better than those for sur-
gery for ERM,  DME,  glaucoma,  and comitant stra-
bismus.  This clinical study was performed against the 
current social background in which the eﬀects of 
medical services on society are assessed according to 
economic eﬃciency from the viewpoint of the eﬀective 
use of medical resources,  and the signiﬁcance of the 
study is related to the fact that it clariﬁes the eﬀects 
of surgical treatments for major ocular diseases on 
vision-related QOL.
Acknowledgments.　Supported by the Grant-in-Aid (No. 22591964) 
and the aid from the Koyama Fund of the Relief Center for the Disabled 
and Patients with Refractory Diseases.
References
 1. Massof RW and Rubin GS: Visual function assessment question-
naires.  Surv Ophthalmol (2001) 45: 531-548.
 2. Brown MM,  Brown GC,  Sharma S and Jennifer L: Health care 
economic analysis and value-based medicine.  Surv Ophthalmol 
(2003) 48: 204-223.
 3. van de Graaf ES,  van der Sterre GW,  Polling JR,  van Kempen-du 
Saar H,  Simonsz B and Simonz HJ: Amblyopia & strabismus 
question naire: design and initial validation.  Strabismus (2004) 
12: 181-193.
 4. Hatt SR,  Leske DA,  Bradley EA,  Cole SR and Holmes JM:  
Compar ison of quality-of-life instruments in adults with strabismus.  
Am J Ophthalmol (2009) 148: 558-562.
 5. Sabri K,  Knapp CM,  Thompson JR and Gottlob I: The VF-14 and 
psychologicl impact of amblyopia and strabismus.  Invest Ophthal-
mol Vis Sci (2006) 47: 4386-4392.
 6. Beauchamp CL,  Beauchamp GR,  Stager Sr DR,  Brown MM,  
Brown GC and Felius J: The cost utility of strabismus surgery in 
adults.  J AAPOS (2006) 10: 394-399.
 7. Fujiike K and Yamada M: QOL Assessment and utility analysis.  
Jpn J Ophthalmic Surgery.  (2010) 23: 426-429 (in Japanese).
 8. Jackson S,  Harrad RA,  Morris M and Rumsey N: The psychoso-
cial beneﬁts of corrective surgery for adults with strabismus.  Br J 
Ophthalmol (2006) 90: 883-888.
 9. Burke JP,  Leach CM and Davis H: Psychosocial implications of 
strabismus surgery in adults.  J Pediatr Ophthalmol Strabismus 
(1997) 34: 159-164.
10. Steinberg EP,  Tielsch JM,  Schein OD,  Javitt JC,  Sharkey P,  
Cassard SD,  Legro MW,  Diener-West M,  Bass EB,  Damiano AM,  
Steinwachs DM and Sommer A: The VF-14 An index of functional 
impairment in patients with cataract.  Arch Ophthalmol (1994) 112:  
630-638.
11. Brown GC: Vision and quality-of-life.  Trans Am Ophthalmol Soc 
(1999) 97: 473-511.
12. Datta S,  Foss AJ,  Grainge MJ,  Gregson RM,  Zaman A,  Masud T,  
Osborn F and Harwood RH: The importance of acuity,  stereopsis,  
and contrast sensitivity for health-related quality of life in elderly 
women with cataracts.  Invest Ophthalmol Vis Sci (2008) 49: 1-6.
13. Fujita A,  Hieda O,  Nakajima N and Kinoshita S: The VF-14 index 
of functional visual impairment in patients with corneal disease 
treated by phototherapeutic keratectomy.  J Jpn Ophthalmol Soc 
(2005) 109: 736-740 (in Japanese).
14. Bland JM and Altman DG: Statistical methods for assessing 
agreement between two methods of clinical measurement.  Lancet 
109VF-14 Questionnaire-based OutcomesApril 2012
(1986) 1: 307-310.
15. Bland JM and Altman DG: Comparing methods of measurement:  
why plotting diﬀerence against standard methods is misleading.  
Lancet (1995) 346: 1085-1087.
16. Hatt SR,  Leske DA,  Kirgis PA,  Bradley EA and Holmes JM: The 
eﬀects of strabismus on quality of life in adults.  Am J Ophthalmol 
(2007) 144: 643-647.
17. Hatt SR,  Leske DA,  Bradley EA,  Cole SR and Holmes JM:  
Development of a quality- of-life questionnaire for adults with stra-
bismus.  Ophthalmology (2009) 116: 139-144.
18. Norregaard JC,  Bernth-Petersen P,  Alonso J,  Dunn E,  Black C,  
Andersen TF,  Espallargues M,  Bellan L and Anderson GF:  
Variation in indications for cataract surgery in the United States,  
Denmark,  Canada,  and Spain: results from the International 
Cataract Surgery Outcomes Study.  Br J Ophthalmol (1998) 
82: 1107-1111.
19. Bilbao A,  Quitana JM,  Escobar A,  García S,  Andradas E,  Baré M,  
Elizalde B and IRYSS-Cataract Group: Responsiveness and clini-
cally important diﬀerences for the VF-14 index,  SF-36,  and visual 
acuity in patients undergoing cataract surgery.  Ophthalmology 
(2009) 116: 418-424.
20. Senba S: Cost-utility analysis of cataract surgery: measuring of 
the value of preference using time trade-oﬀ method.  Tokyo Univer-
sity,  Doctorate Thesis (Medicine) 1121220,  (2009).
21. Yamada M,  Mizuno Y,  Miyake Y and Cataract Survey Group of 
the National Hospital Organization of Japan: A multicenter study 
on the health-related quality of life of cataract patients: baseline 
data.  Jpn J Ophthalmol (2009) 53: 470-476.
22. Mozaﬀarieh M,  Krepler K,  Heinzl H,  Sacu S and Wedrich A: Visual 
function,  quality of life and patient satisfaction after ophthalmic 
surgery: A comparative study.  Opthalmologica (2004) 218: 26-30.
23. Spaeth G,  Walt J and Keener J: Evaluation of quality of life for 
patients with glaucoma.  Am J Ophthalmol (2006) 141: 3-14.
24. Parrish RK,  Gedde SJ,  Scott IU,  Feuer WJ,  Schiﬀman JC,  
Mangione CM and Montenegro-Piniella A: Visual function and 
quality of life among patients with glaucoma.  Arch Ophthalmol 
(1997) 115: 1447-1455.
25. Nah YS,  Seong GJ and Kim CY: Visual function and quality of life 
in Korean patients with glaucoma.  Korean J Ophthalmol (2002) 
16: 70-74.
26. Mckean-Cowdin R,  Wang Y,  MS J Wu,  Azen SP and Varma R: Los 
Angeles Latino Eye Study Group: Impact of visual ﬁeld loss on 
health-related quality of life in glaucoma.  The Los Angeles Latino 
Eye Study.  Ophthalmology (2008) 115: 941-948.
27. Evans K,  Law SK,  Walt J,  Buchholz P and Hansen J: The quality 
of life impact of peripheral versus central vision loss with a focus 
on glaucoma versus age-related macular degeneration.  Clin 
Ophthal mol (2009) 3: 433-445.
28. Hariprasad SM,  Mieler WF,  Grassi M,  Green JL,  Jager RD and 
Miller L: Vision－related quality of life in patients with diabetic 
macular oedema.  Br J Ophthalmol (2008) 92: 89-92.
29. Okamoto F,  Okamoto Y,  Fukuda S,  Hiraoka T and Oshika T:  
Vision-related quality of life and visual function after vitrectomy for 
various vitreoretinal disorders.  Invest Ophthalmol Vis Sci (2010) 
51: 744-751.
30. Okamoto F,  Okamoto Y,  Fukuda S,  Hiraoka T and Oshika T:  
Vision-related quality of life and visual function following vitrec-
tomy for proliferative diabetic retinopathy.  Am J Ophthalmol (2008) 
145: 1031-1036.
110 Acta Med.  Okayama　Vol.  66,  No.  2Kishimoto et al.
